Intellipharmaceutics International (IPCI) Misses Q2 EPS by 2c

Intellipharmaceutics International (NASDAQ: IPCI) reported Q2 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $1.4 million.

For earnings history and earnings-related data on Intellipharmaceutics International (IPCI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c